(±)-E-5-[3-(二甲氨基)丙叉基]-10.11-二氢-5H-二苯并[A,D]环庚烯-10-醇

更新时间:2024-01-06 12:29:50

(±)-E-5-[3-(二甲氨基)丙叉基]-10.11-二氢-5H-二苯并[A,D]环庚烯-10-醇结构式
(±)-E-5-[3-(二甲氨基)丙叉基]-10.11-二氢-5H-二苯并[A,D]环庚烯-10-醇结构式
品牌特惠专场
常用名 (±)-E-5-[3-(二甲氨基)丙叉基]-10.11-二氢-5H-二苯并[A,D]环庚烯-10-醇 英文名 amitriptyline metabolite (+/-)-
CAS号 64520-05-4 分子量 293.40300
密度 1.151g/cm3 沸点 453.3ºC at 760mmHg
分子式 C20H23NO 熔点 97-99 °C
MSDS 美版 闪点 225.4ºC

 名称

中文名 (±)-E-5-[3-(二甲氨基)丙叉基]-10.11-二氢-5H-二苯并[a,d]环庚烯-10-醇
英文名 (11E)-11-[3-(dimethylamino)propylidene]-5,6-dihydrodibenzo[2,1-b:2',1'-f][7]annulen-5-ol
英文别名 更多

 物理化学性质

密度 1.151g/cm3
沸点 453.3ºC at 760mmHg
熔点 97-99 °C
分子式 C20H23NO
分子量 293.40300
闪点 225.4ºC
精确质量 293.17800
PSA 23.47000
LogP 3.65950
外观性状 solid | white
折射率 1.651
水溶解性 0.1 M HCl: soluble

 安全信息

个人防护装备 Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
安全声明 (欧洲) 22-24/25
危险品运输编码 NONH for all modes of transport
WGK德国 3

 合成线路

~%

(±)-E-5-[3-(二甲氨基)丙叉基]-10.11-二氢-5H-二苯并[A,D]环庚烯-10-醇结构式

(±)-E-5-[3-(二甲氨...

64520-05-4

文献:Lassen; Perregaard 1983 , vol. 37, # 4 B p. 335 - 340

~%

(±)-E-5-[3-(二甲氨基)丙叉基]-10.11-二氢-5H-二苯并[A,D]环庚烯-10-醇结构式

(±)-E-5-[3-(二甲氨...

64520-05-4

文献:Lassen; Perregaard 1983 , vol. 37, # 4 B p. 335 - 340

~%

(±)-E-5-[3-(二甲氨基)丙叉基]-10.11-二氢-5H-二苯并[A,D]环庚烯-10-醇结构式

(±)-E-5-[3-(二甲氨...

64520-05-4

文献:Lassen; Perregaard 1983 , vol. 37, # 4 B p. 335 - 340

~%

(±)-E-5-[3-(二甲氨基)丙叉基]-10.11-二氢-5H-二苯并[A,D]环庚烯-10-醇结构式

(±)-E-5-[3-(二甲氨...

64520-05-4

文献:Lassen; Perregaard 1983 , vol. 37, # 4 B p. 335 - 340

~%

(±)-E-5-[3-(二甲氨基)丙叉基]-10.11-二氢-5H-二苯并[A,D]环庚烯-10-醇结构式

(±)-E-5-[3-(二甲氨...

64520-05-4

文献:Olesen, Ole V.; Linnet, Kristian Pharmacology, 1997 , vol. 55, # 5 p. 235 - 243

~%

(±)-E-5-[3-(二甲氨基)丙叉基]-10.11-二氢-5H-二苯并[A,D]环庚烯-10-醇结构式

(±)-E-5-[3-(二甲氨...

64520-05-4

文献:Masubuchi, Yasuhiro; Iwasa, Takashi; Fujita, Shoichi; Suzuki, Tokuji; Horie, Toshiharu; Narimatsu, Shizuo Journal of Pharmacy and Pharmacology, 1996 , vol. 48, # 9 p. 925 - 929

 文献15

更多文献
Enantioselective amitriptyline metabolism in patients phenotyped for two cytochrome P450 isozymes.

Clin. Pharmacol. Ther. 52(4) , 350-8, (1992)

In 26 hospitalized patients with depression, a combined pharmacogenetic test with dextromethorphan, a substrate of cytochrome P450IID6, and mephenytoin, the S-form of which is hydroxylated by a P450II...

Demethylation and hydroxylation of amitriptyline, nortriptyline, and 10-hydroxyamitriptyline in human liver microsomes.

Drug Metab. Dispos. 9(6) , 565-8, (1981)

The rates of demethylation and hydroxylation of amitriptyline, nortriptyline, and 10-hydroxyamitriptyline by microsomes from adult human livers were determined by use of mass-fragmentographic or liqui...

CYP2D6 and CYP2C19 genotypes and amitriptyline metabolite ratios in a series of medicolegal autopsies.

Forensic Sci. Int. 158(2-3) , 177-83, (2006)

In a series of 202 postmortem toxicology cases, the CYP2D6 and CYP2C19 genes were genotyped, and the concentrations of amitriptyline (AT) and six metabolites were analyzed. The polymorphic CYP2D6 and ...

 英文别名

5H-Dibenzo(a,d)cyclohepten-10-ol,5-(3-(dimethylamino)propylidene)-10,11-dihydro-,(E)
( inverted exclamation markA)-(E)-5-[3-(Dimethylamino)propylidene]-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-10-ol
Amitriptyline metabolite,( inverted exclamation markA)-E-10-hydroxylated